Status:
COMPLETED
Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia
Lead Sponsor:
Luzerner Kantonsspital
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
There is a lack of data on the prognostic importance of silent ischemia in totally asymptomatic subjects without history of coronary artery disease (CAD), and, particularly, on a possible benefit of m...
Detailed Description
Although there is still controversy regarding why ischemic episodes are symptomatic in some patients and completely asymptomatic in others, it is now widely accepted that silent ischemia, like symptom...
Eligibility Criteria
Inclusion
- Documented silent myocardial ischemia type I
- At least one cardiovascular risk factor
Exclusion
- History of cardiovascular disease
Key Trial Info
Start Date :
February 1 1992
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00382421
Start Date
February 1 1992
End Date
April 1 2006
Last Update
October 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Hospital Lucerne
Lucerne, Canton of Lucerne, Switzerland, 6000